[Allergy risk assessment and surveillance]

Charlotte Chevillard; Laetitia Quercy; Olivier Aubertin; Geoffroy Rousseau; Nicolas Bounaud

doi:10.1016/j.revinf.2022.05.007

[Allergy risk assessment and surveillance]

Rev Infirm. 2022 Jun-Jul;71(282):18-20. doi: 10.1016/j.revinf.2022.05.007. Epub 2022 May 26.

[Article in French]

Authors

Charlotte Chevillard¹, Laetitia Quercy¹, Olivier Aubertin¹, Geoffroy Rousseau², Nicolas Bounaud³

Affiliations

¹ Urgences-Samu-Smur, CH Montauban, 100 rue Léon-Cladel, 82000 Montauban, France.
² Département de médecine d'urgence, CHRU Tours, avenue de la République, 37170 Chambray-lès-Tours, France.
³ Urgences-Samu-Smur, CH Montauban, 100 rue Léon-Cladel, 82000 Montauban, France. Electronic address: n.bounaud@ch-montauban.fr.

PMID: 36150832
DOI: 10.1016/j.revinf.2022.05.007

Abstract

The assessment of a patient's allergic risk can be based on the ABCDE methodology to be standardized. Hospital monitoring should be routine in case of signs of anaphylaxis.

Keywords: allergie; allergy; anaphylaxie; anaphylaxis; assessment; method; méthode; surveillance; évaluation.

MeSH terms

Anaphylaxis* / diagnosis
Drug Hypersensitivity* / diagnosis
Humans
Risk Assessment